BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23007074)

  • 1. Main determinants of PON1 activity in hemodialysis patients.
    Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
    Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.
    Ribeiro S; Faria Mdo S; Silva G; Nascimento H; Rocha-Pereira P; Miranda V; Vieira E; Santos R; Mendonça D; Quintanilha A; Costa E; Belo L; Santos-Silva A
    Hemodial Int; 2012 Oct; 16(4):481-90. PubMed ID: 22515595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.
    Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW
    Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
    Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
    Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease.
    Samouilidou E; Kostopoulos V; Liaouri A; Kioussi E; Vassiliou K; Bountou E; Grapsa E
    Ren Fail; 2016 Nov; 38(10):1601-1606. PubMed ID: 26888625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.
    Rajković MG; Barišić K; Juretić D; Grubišić TŽ; Flegar-Meštrić Z; Rumora L
    Clin Biochem; 2011 Aug; 44(12):964-8. PubMed ID: 21620813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
    Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.
    de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M
    Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase 1 status in the Thai population.
    Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B
    J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease.
    Sztanek F; Seres I; Harangi M; Lőcsey L; Koncsos P; Paragh G
    Kidney Blood Press Res; 2012; 36(1):310-9. PubMed ID: 23235285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with fluvastatin rapidly modulates, via different pathways, and in dependence on the baseline level, inflammation in hemodialysis patients.
    Tsirpanlis G; Boufidou F; Manganas S; Chantzis K; Bleta A; Stamatelou K; Psimenou E; Nicolaou C
    Blood Purif; 2004; 22(6):518-24. PubMed ID: 15557765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy.
    Pérez-Herrera N; May-Pech C; Hernández-Ochoa I; Castro-Mañé J; Rojas-García E; Borja-Aburto VH; Castillo-Burguete T; Quintanilla-Vega B
    Exp Mol Pathol; 2008 Oct; 85(2):129-34. PubMed ID: 18582459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients.
    Rahimi-Ardabili B; Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Naghavi-Behzad M; Ghorashi S; Nezami N
    Ren Fail; 2012; 34(9):1123-8. PubMed ID: 22950600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malnutrition, inflammation, and lipids in a cohort of dialysis patients.
    Bowden RG; Wilson RL
    Postgrad Med; 2010 May; 122(3):196-202. PubMed ID: 20463430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.